Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy in Bipolar Rapid Cycling
NCT00063362Phase 3Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Feb 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of lamotrigine in bipolar disorder (BD) (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Proportion of Patients Who Experience a Marked and Persistent Bimodal Response at 28 weeks. Started Feb 2002; status: terminated.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00063362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063362.